umbilical cord blood-derived CD4+/CD25+ T-regulatory cells CK0801
Term · Oncology and biomedicine · MLC-T-ONC-017397
A preparation composed of allogeneic umbilical cord blood (UCB)-derived, ex vivo expanded and enhanced CD4+/CD25+ T-regulatory cells (Tregs) with potential immunomodulatory activity. Upon administration, the UCB-derived CD4+/CD25+ Tregs CK0801 may promote immunologic homeostasis and prevent autoimmunity by suppressing self-reactive T cells. This may induce tolerance to allogeneic organ transplants, prevent graft-versus-host disease (GvHD), and suppress autoimmune pathology.
| Identifier | MLC-T-ONC-017397 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | UCB-derived CD4+CD25+ Tregs CK0801 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017397",
"term": "umbilical cord blood-derived CD4+/CD25+ T-regulatory cells CK0801",
"field": "Oncology and biomedicine",
"definition": "A preparation composed of allogeneic umbilical cord blood (UCB)-derived, ex vivo expanded and enhanced CD4+/CD25+ T-regulatory cells (Tregs) with potential immunomodulatory activity. Upon administration, the UCB-derived CD4+/CD25+ Tregs CK0801 may promote immunologic homeostasis and prevent autoimmunity by suppressing self-reactive T cells. This may induce tolerance to allogeneic organ transplants, prevent graft-versus-host disease (GvHD), and suppress autoimmune pathology.",
"synonyms": [
"UCB-derived CD4+CD25+ Tregs CK0801"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/umbilical-cord-blood-derived-cd4-plus-cd25-plus-t-regulatory-cells-ck0801/"
}
Record 16,924 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.